Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study - Kim, Dong Wook; Saußele, Susanne (Annals of hematology, 2018)
Gesehen am 18.10.2019